EVLV vs. MAZE
EVLV (Evolv Technologies Holdings Inc) and MAZE (Maze Therapeutics, Inc) are both stocks. EVLV operates in Security & Protection Services (Industrials), while MAZE operates in Biotechnology (Healthcare). Over the past year, EVLV returned 17.57% vs 77.49% for MAZE. At a 0.02 correlation, their price movements are largely independent.
Performance
EVLV vs. MAZE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EVLV achieves a -14.94% return, which is significantly higher than MAZE's -41.95% return.
EVLV
- 1D
- -0.81%
- 1M
- 1.16%
- YTD
- -14.94%
- 6M
- -13.12%
- 1Y
- 17.57%
- 3Y*
- -1.38%
- 5Y*
- -9.60%
- 10Y*
- —
MAZE
- 1D
- -0.17%
- 1M
- -10.79%
- YTD
- -41.95%
- 6M
- -38.11%
- 1Y
- 77.49%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
EVLV vs. MAZE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
EVLV Evolv Technologies Holdings Inc | -14.94% | 79.00% |
MAZE Maze Therapeutics, Inc | -41.95% | 157.01% |
Correlation
The correlation between EVLV and MAZE is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Jan 31, 2025 | 0.02 |
Fundamentals
EVLV:
$1.08B
MAZE:
$1.30B
EVLV:
-$0.21
MAZE:
-$2.63
EVLV:
8.94
MAZE:
3.79
EVLV:
$160.23M
MAZE:
$0.00
EVLV:
$79.75M
MAZE:
-$1.15M
EVLV:
-$39.27M
MAZE:
-$126.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EVLV vs. MAZE — Risk / Return Rank
EVLV
MAZE
EVLV vs. MAZE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Evolv Technologies Holdings Inc (EVLV) and Maze Therapeutics, Inc (MAZE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EVLV | MAZE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.53 | ||
| Sortino ratioReturn per unit of downside risk | -1.07 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.27 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.40 | 1.43 | -1.03 |
| Martin ratioReturn relative to average drawdown | 0.75 | 3.16 | -2.41 |
Loading charts...
Drawdowns
EVLV vs. MAZE - Drawdown Comparison
The maximum EVLV drawdown since its inception was -84.50%, which is greater than MAZE's maximum drawdown of -54.51%. Use the drawdown chart below to compare losses from any high point for EVLV and MAZE.
Loading charts...
Drawdown Indicators
| EVLV | MAZE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.50% | -54.51% | -29.99% |
Max Drawdown (1Y)Largest decline over 1 year | -44.06% | -54.51% | +10.45% |
Max Drawdown (3Y)Largest decline over 3 years | -72.92% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -84.21% | — | — |
Current DrawdownCurrent decline from peak | -44.13% | -53.60% | +9.47% |
Average DrawdownAverage peak-to-trough decline | -50.29% | -20.99% | -29.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.37% | 24.60% | -1.23% |
Volatility
EVLV vs. MAZE - Volatility Comparison
Evolv Technologies Holdings Inc (EVLV) has a higher volatility of 15.37% compared to Maze Therapeutics, Inc (MAZE) at 11.72%. This indicates that EVLV's price experiences larger fluctuations and is considered to be riskier than MAZE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EVLV | MAZE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.37% | 11.72% | +3.65% |
Volatility (6M)Calculated over the trailing 6-month period | 38.87% | 56.26% | -17.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.43% | 89.54% | -37.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 86.01% | 94.20% | -8.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.57% | 94.20% | -13.63% |
Dividends
EVLV vs. MAZE - Dividend Comparison
Neither EVLV nor MAZE has paid dividends to shareholders.
Financials
EVLV vs. MAZE - Financials Comparison
This section allows you to compare key financial metrics between Evolv Technologies Holdings Inc and Maze Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
EVLV and MAZE have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EVLV has higher volatility (15.37%) compared to MAZE (11.72%). In terms of maximum drawdown, EVLV dropped -84.50% vs MAZE's -54.51%.
MAZE currently has the higher Sharpe Ratio (0.87 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EVLV and MAZE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer